WILMINGTON, Del., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Securities Hematology and Oncology Summit, taking place virtually on December 2, 2024.
Read more at globenewswire.comPrelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit
PRELUDE THERAPEUTICS INC
NASDAQ:PRLD (2/11/2025, 11:46:15 AM)
0.9603
-0.13 (-11.9%)
PRLD Latest News and Analysis
19 hours ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
